NorthRock Partners’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Buy
+3,389
New +$183K ﹤0.01% 605
2025
Q4
Sell
-11,133
Closed -$619K 884
2025
Q3
$619K Buy
11,133
+1,952
+21% +$105K 0.01% 473
2025
Q2
$472K Buy
9,181
+2,245
+32% +$113K 0.01% 415
2025
Q1
$407K Buy
6,936
+277
+4% +$18.8K 0.01% 399
2024
Q4
$480K Buy
6,659
+610
+10% +$44.8K 0.02% 369
2024
Q3
$483K Buy
6,049
+60
+1% +$4.51K 0.02% 374
2024
Q2
$429K Buy
5,989
+555
+10% +$40.8K 0.02% 380
2024
Q1
$382K Buy
5,434
+79
+1% +$5.65K 0.01% 422
2023
Q4
$413K Buy
5,355
+1,812
+51% +$119K 0.02% 377
2023
Q3
$241K Sell
3,543
-667
-16% -$52.7K 0.03% 284
2023
Q2
$344K Sell
4,210
-177
-4% -$14.2K 0.04% 192
2023
Q1
$325K Buy
4,387
+82
+2% +$6.32K 0.03% 209
2022
Q4
$357K Buy
4,305
+837
+24% +$66.5K 0.04% 214
2022
Q3
$246K Buy
3,468
+76
+2% +$6.57K 0.03% 247
2022
Q2
$294K Sell
3,392
-784
-19% -$73.5K 0.03% 220
2022
Q1
$452K Buy
4,176
+876
+27% +$90.4K 0.04% 187
2021
Q4
$427K Buy
+3,300
New +$405K 0.03% 196

Other funds holding TECH

NorthRock Partners's TECH Position: Q2 2026 in Review

NorthRock Partners opened a new position in Bio-Techne (TECH) in Q2 2026: 3,389 shares worth $239K. The stake represents ﹤0.01% of the portfolio and ranks #605 among its holdings. This is a return to the name: NorthRock Partners previously reported a position in TECH as recently as Q3 2025.

NorthRock Partners first reported a position in TECH in Q4 2021 and has held it in 17 quarters since. The position peaked at $619K in Q3 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • NorthRock Partners held 3,389 shares of Bio-Techne worth $239K as of Q2 2026.
  • Bio-Techne was a new NorthRock Partners position in Q2 2026.
  • Bio-Techne made up ﹤0.01% of NorthRock Partners's portfolio in Q2 2026, its #605 holding.
  • NorthRock Partners first reported a position in Bio-Techne in Q4 2021 and has held it in 17 quarters since.
  • NorthRock Partners's Bio-Techne position peaked at $619K in Q3 2025.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.